Recruiting studies: Bone Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06988020 Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell
Phase N/A · 19 location(s) · AO Innovation Translation Center · NCT04098146 Haplo-Cord HSCT for AML/MDS
NA · 4 location(s) · Fujian Medical University Union Hospital · NCT07588360 Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma
Phase 2 · 1 location(s) · Institut Claudius Regaud · NCT04515459 Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1/Phase 2 · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06648096 Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.
Phase 3 · 1 location(s) · XIANG YANQUN · NCT06383780 Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMM
Phase N/A · 1 location(s) · University Hospital Freiburg · NCT00662090 Toripalimab Combined With CAV/IE Regimen
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT04589741 T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissu
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06474676 Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT07321626 Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Phase 1 · 4 location(s) · Cellenkos, Inc. · NCT05423691 Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of
Phase 4 · 3 location(s) · Ottawa Hospital Research Institute · NCT05753618 Natural History Study of Parathyroid Disorders
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT04969926 A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Phase 1 · 53 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT04227847 AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positiv
Phase 3 · 42 location(s) · University Hospital, Brest · NCT05198960 RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT07030569 Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969 Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Phase N/A · 3 location(s) · Barts & The London NHS Trust · NCT00461188 A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in
Phase 1 · 2 location(s) · Mayo Clinic · NCT03017820 Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors
Phase N/A · 1 location(s) · Henan Cancer Hospital · NCT05468970 Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metas
Phase 1 · 5 location(s) · Kiromic BioPharma Inc. · NCT06069570 A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07500753 ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas
Phase 2 · 11 location(s) · Hansoh BioMedical R&D Company · NCT05830123 Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT06839456 Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
NA · 1 location(s) · University of Nebraska · NCT04898790 Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplas
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT07228624 Olverembatinib for FGFR1-rearranged Neoplasms
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT05521204 Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological M
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT04195633 Single Arm Romiplostim to Prevent CIT
EARLY_Phase 1 · 2 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07048249 A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Pa
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT07020533

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.